查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1612963

截肢後慢性疼痛管理市場：按類型、治療類型、最終用戶分類 - 全球預測 2025-2030

Chronic Post-Amputation Pain Management Market by Type (Neuroma Pain, Phantom Limb Pain, Stump Pain), Treatment Type (Medication, Neuromodulation Techniques, Surgical Interventions), End-Use - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年截肢後慢性疼痛管理市場價值為56.5億美元，預計到2024年將達到59.6億美元，複合年成長率為5.66%，到2030年將達到83.1億美元，預計將達到1000萬美元。

截肢後慢性疼痛管理總結了緩解截肢後持續疼痛的策略和治療方法。這個市場對於改善經常遭受幻肢痛或殘肢痛的截肢者的生活品質至關重要。截肢者面臨巨大的身體和心理挑戰，其醫療需求未被滿足，凸顯了有效疼痛管理的必要性。應用範圍從止痛藥和抗憂鬱劑等藥物到神經阻斷、脊髓刺激和經皮神經電刺激等進階治療。最終用途主要包括醫療保健提供者、復健中心和疼痛管理診所。

主要市場統計
基準年[2023] 56.5億美元
預測年份 [2024] 59.6億美元
預測年份 [2030] 83.1億美元
複合年成長率（%） 5.66%

由於糖尿病和周邊動脈疾病盛行率上升，截肢人數不斷增加，影響了市場的成長。疼痛管理療法的技術進步、對個人化醫療的重視以及人工智慧在疼痛結果預測模型開發中的整合正在創造潛在的商機。為了利用這些機會，公司應專注於探索合作夥伴關係和新型藥物輸送系統。然而，高昂的治療費用、糟糕的報銷政策以及疼痛評估的複雜性等障礙限制了市場的擴張。

挑戰包括高誤診率和使治療方法複雜化的疼痛心理方面。為了實現業務成長，創新應針對非鴉片類疼痛管理解決方案和允許遠端監測疼痛程度的數位療法。虛擬實境和神經調節技術的引入是有前途的研究途徑。競爭激烈且分散的市場需要策略重點關注利基領域，例如兒科疼痛管理和針對特定患者群體的干涉措施。對臨床試驗和患者教育的持續投資可以提高治療的可接受性並加速市場滲透。為了應對這一不斷變化的形勢，公司必須優先考慮以患者為中心的解決方案和強大的相關人員協作。

市場動態：揭示快速發展的截肢後慢性疼痛管理市場的關鍵市場洞察

供需的動態交互作用正在改變截肢後慢性疼痛管理市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 提高對疼痛管理方案的認知並改善醫療基礎設施
    • 對藥物和非藥物疼痛管理療法的偏好日益增加
    • 政府支持政策和醫療報銷制度
  • 市場限制因素
    • 昂貴的治療費用
  • 市場機會
    • 神經調節技術的不斷進步
    • 需要以患者為中心的醫療保健模式，強調個人化治療計劃
  • 市場挑戰
    • 專業醫護人員短缺及藥物副作用問題

波特五力：駕馭截肢後慢性疼痛管理市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解截肢後慢性疼痛管理市場的外部影響

外部宏觀環境因素在塑造截肢後慢性疼痛管理市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解截肢後慢性疼痛管理市場的競爭格局

對截肢後慢性疼痛管理市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣截肢後慢性疼痛管理市場供應商的績效評估

FPNV 定位矩陣是評估截肢後慢性疼痛管理市場供應商的關鍵工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議，規劃截肢後慢性疼痛管理市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，截肢後慢性疼痛管理市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5.產品開發與創新：重點關注可望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 提高對疼痛管理方法的認知並改善醫療基礎設施
      • 人們對藥物和非藥物疼痛管理療法越來越感興趣。
      • 政府支持政策和醫療報銷
    • 抑制因素
      • 治療方案成本高
    • 機會
      • 神經調節技術的不斷進步
      • 需要以患者為中心的醫療保健模式，強調個人化治療計劃
    • 任務
      • 專業醫護人員短缺、藥物副作用等問題
  • 市場區隔分析
    • 類型：對幻肢痛管理以緩解疼痛和提高生活品質的需求不斷成長
    • 最終用途：醫院截肢後慢性疼痛管理的需求不斷增加
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章截肢後慢性疼痛管理市場：依類型

  • 神經瘤疼痛
  • 幻肢痛
  • 切面疼痛

第7章依治療類型分類的截肢後慢性疼痛管理市場

  • 藥物治療
  • 神經調節技術
  • 手術介入
  • 治療
    • 鏡子療法
    • 物理治療
    • 心理治療

第8章截肢後慢性疼痛管理市場：依最終用途分類

  • 居家護理
  • 醫院
  • 疼痛診所
  • 復健中心

第9章美洲截肢後慢性疼痛管理市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太地區截肢後慢性疼痛管理市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章歐洲/中東/非洲截肢後慢性疼痛管理市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • Trinity Capital 投資 Neuros Medical 以加強截肢者的疼痛管理
  • 戰略分析和建議

公司名單

  • Abbott Laboratories
  • Advanced Arm Dynamics, Inc.
  • Aspen Pharmacare Holdings Limited
  • AstraZeneca PLC
  • ATI Physical Therapy
  • B. Braun Melsungen AG
  • Einstein Healthcare Network
  • GlaxoSmithKline PLC
  • Memorial Healthcare System
  • Novartis AG
  • Pfizer Inc.
  • Physiopedia
  • Propel Physiotherapy
  • Select Medical Corporation
  • Smart Solutions Rehab Group
  • Teva Pharmaceutical Industries Ltd.
  • The Rehabilitation Hospital of Montana
Product Code: MRR-99555D550529

The Chronic Post-Amputation Pain Management Market was valued at USD 5.65 billion in 2023, expected to reach USD 5.96 billion in 2024, and is projected to grow at a CAGR of 5.66%, to USD 8.31 billion by 2030.

Chronic Post-Amputation Pain Management encapsulates the strategies and treatments designed to alleviate persistent pain experienced by individuals following limb amputation. This market is critical in enhancing the quality of life for amputees, who often suffer from phantom limb pain or residual limb pain. The necessity of effective pain management is underscored by the unmet medical needs of amputees facing significant physical and psychological challenges. Applications range from pharmaceutical medications, such as analgesics and antidepressants, to advanced therapies like nerve blocks, spinal cord stimulation, and transcutaneous electrical nerve stimulation. The end-use scope primarily includes healthcare providers, rehabilitation centers, and specialized pain management clinics.

KEY MARKET STATISTICS
Base Year [2023] USD 5.65 billion
Estimated Year [2024] USD 5.96 billion
Forecast Year [2030] USD 8.31 billion
CAGR (%) 5.66%

The market growth is being influenced by an increasing number of amputation surgeries due to rising incidences of diabetes and peripheral arterial disease. Technological advancements in pain management therapies, a greater emphasis on personalized medicine, and the integration of artificial intelligence in developing predictive models for pain outcomes are creating potential opportunities. Companies should focus on collaborative partnerships and exploring novel drug-delivery systems to tap into these opportunities. However, barriers such as high treatment costs, inadequate reimbursement policies, and the complexity of pain assessment limit market expansion.

Challenging factors include the high rate of misdiagnosis and the psychological aspect of pain that complicates treatment regimens. For business growth, innovation should target non-opioid pain management solutions and digital therapeutics that can monitor pain levels remotely. Incorporation of virtual reality and neuromodulation technologies offers promising research avenues. The market is competitive and fragmented, requiring a strategic focus on niche segments like pediatric pain management and tailored interventions for specific patient demographics. Continued investment in clinical trials and patient education can enhance treatment acceptance and drive market penetration. To navigate this evolving landscape, companies must prioritize patient-centric solutions and robust stakeholder collaboration.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Chronic Post-Amputation Pain Management Market

The Chronic Post-Amputation Pain Management Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising awareness of pain management options and better healthcare infrastructure
    • Increasing preference for pharmacological and non-pharmacological pain management therapies
    • Supportive government policies and healthcare reimbursement
  • Market Restraints
    • High cost of treatment options
  • Market Opportunities
    • Ongoing advancements in neuromodulation technologies
    • Need for patient-centric healthcare models emphasizing personalized treatment plans
  • Market Challenges
    • Limited availability of specialized medical professionals and issues associated with medication side effects

Porter's Five Forces: A Strategic Tool for Navigating the Chronic Post-Amputation Pain Management Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Chronic Post-Amputation Pain Management Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Chronic Post-Amputation Pain Management Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Chronic Post-Amputation Pain Management Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Chronic Post-Amputation Pain Management Market

A detailed market share analysis in the Chronic Post-Amputation Pain Management Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Chronic Post-Amputation Pain Management Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Chronic Post-Amputation Pain Management Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Chronic Post-Amputation Pain Management Market

A strategic analysis of the Chronic Post-Amputation Pain Management Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Chronic Post-Amputation Pain Management Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Advanced Arm Dynamics, Inc., Aspen Pharmacare Holdings Limited, AstraZeneca PLC, ATI Physical Therapy, B. Braun Melsungen AG, Einstein Healthcare Network, GlaxoSmithKline PLC, Memorial Healthcare System, Novartis AG, Pfizer Inc., Physiopedia, Propel Physiotherapy, Select Medical Corporation, Smart Solutions Rehab Group, Teva Pharmaceutical Industries Ltd., and The Rehabilitation Hospital of Montana.

Market Segmentation & Coverage

This research report categorizes the Chronic Post-Amputation Pain Management Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Neuroma Pain, Phantom Limb Pain, and Stump Pain.
  • Based on Treatment Type, market is studied across Medication, Neuromodulation Techniques, Surgical Interventions, and Therapy. The Therapy is further studied across Mirror Therapy, Physical Therapy, and Psychological Therapy.
  • Based on End-Use, market is studied across Home Care, Hospitals, Pain Clinics, and Rehabilitation Centers.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising awareness of pain management options and better healthcare infrastructure
      • 5.1.1.2. Increasing preference for pharmacological and non-pharmacological pain management therapies
      • 5.1.1.3. Supportive government policies and healthcare reimbursement
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of treatment options
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing advancements in neuromodulation technologies
      • 5.1.3.2. Need for patient-centric healthcare models emphasizing personalized treatment plans
    • 5.1.4. Challenges
      • 5.1.4.1. Limited availability of specialized medical professionals and issues associated with medication side effects
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Increasing demand for phantom limb pain management to enhance quality of life by relieving pain
    • 5.2.2. End-Use: Growing need for chronic post-amputation pain management in hospitals
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Chronic Post-Amputation Pain Management Market, by Type

  • 6.1. Introduction
  • 6.2. Neuroma Pain
  • 6.3. Phantom Limb Pain
  • 6.4. Stump Pain

7. Chronic Post-Amputation Pain Management Market, by Treatment Type

  • 7.1. Introduction
  • 7.2. Medication
  • 7.3. Neuromodulation Techniques
  • 7.4. Surgical Interventions
  • 7.5. Therapy
    • 7.5.1. Mirror Therapy
    • 7.5.2. Physical Therapy
    • 7.5.3. Psychological Therapy

8. Chronic Post-Amputation Pain Management Market, by End-Use

  • 8.1. Introduction
  • 8.2. Home Care
  • 8.3. Hospitals
  • 8.4. Pain Clinics
  • 8.5. Rehabilitation Centers

9. Americas Chronic Post-Amputation Pain Management Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Chronic Post-Amputation Pain Management Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Chronic Post-Amputation Pain Management Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Trinity Capital Invested in Neuros Medical to Enhance Pain Management for Amputees
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Advanced Arm Dynamics, Inc.
  • 3. Aspen Pharmacare Holdings Limited
  • 4. AstraZeneca PLC
  • 5. ATI Physical Therapy
  • 6. B. Braun Melsungen AG
  • 7. Einstein Healthcare Network
  • 8. GlaxoSmithKline PLC
  • 9. Memorial Healthcare System
  • 10. Novartis AG
  • 11. Pfizer Inc.
  • 12. Physiopedia
  • 13. Propel Physiotherapy
  • 14. Select Medical Corporation
  • 15. Smart Solutions Rehab Group
  • 16. Teva Pharmaceutical Industries Ltd.
  • 17. The Rehabilitation Hospital of Montana

LIST OF FIGURES

  • FIGURE 1. CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET RESEARCH PROCESS
  • FIGURE 2. CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET DYNAMICS
  • TABLE 7. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY NEUROMA PAIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY PHANTOM LIMB PAIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY STUMP PAIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY MEDICATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY NEUROMODULATION TECHNIQUES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY SURGICAL INTERVENTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY MIRROR THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY PHYSICAL THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY PSYCHOLOGICAL THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY HOME CARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY PAIN CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY REHABILITATION CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. CANADA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. MEXICO CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. MEXICO CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 45. MEXICO CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 49. UNITED STATES CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 50. UNITED STATES CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 54. ASIA-PACIFIC CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 55. ASIA-PACIFIC CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. AUSTRALIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. AUSTRALIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 59. AUSTRALIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. CHINA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. CHINA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 63. CHINA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. INDIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. INDIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 67. INDIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. INDONESIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. INDONESIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 71. INDONESIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. JAPAN CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. JAPAN CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 75. JAPAN CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. MALAYSIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. MALAYSIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 79. MALAYSIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. PHILIPPINES CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. PHILIPPINES CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 83. PHILIPPINES CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. SINGAPORE CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. SINGAPORE CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 87. SINGAPORE CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH KOREA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. SOUTH KOREA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 91. SOUTH KOREA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. TAIWAN CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. TAIWAN CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 95. TAIWAN CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. THAILAND CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. THAILAND CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 99. THAILAND CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. VIETNAM CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. VIETNAM CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 103. VIETNAM CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. DENMARK CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. DENMARK CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 112. DENMARK CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. EGYPT CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. EGYPT CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 116. EGYPT CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. FINLAND CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. FINLAND CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 120. FINLAND CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. FRANCE CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. FRANCE CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 124. FRANCE CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. GERMANY CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. GERMANY CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 128. GERMANY CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. ISRAEL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. ISRAEL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 132. ISRAEL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. ITALY CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. ITALY CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 136. ITALY CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. NETHERLANDS CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. NETHERLANDS CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 140. NETHERLANDS CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. NIGERIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. NIGERIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 144. NIGERIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. NORWAY CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. NORWAY CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 148. NORWAY CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. POLAND CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 151. POLAND CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 152. POLAND CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. QATAR CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. QATAR CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 156. QATAR CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 158. RUSSIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 159. RUSSIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 160. RUSSIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 162. SAUDI ARABIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 163. SAUDI ARABIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 164. SAUDI ARABIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH AFRICA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 167. SOUTH AFRICA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 168. SOUTH AFRICA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. SPAIN CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. SPAIN CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 172. SPAIN CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 174. SWEDEN CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. SWEDEN CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 176. SWEDEN CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 178. SWITZERLAND CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 179. SWITZERLAND CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 180. SWITZERLAND CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 182. TURKEY CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 183. TURKEY CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 184. TURKEY CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED ARAB EMIRATES CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED ARAB EMIRATES CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED ARAB EMIRATES CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED KINGDOM CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 191. UNITED KINGDOM CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 192. UNITED KINGDOM CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 193. CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 194. CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET, FPNV POSITIONING MATRIX, 2023